Cargando…
Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652531/ http://dx.doi.org/10.1186/2051-1426-3-S2-P445 |
_version_ | 1782401774580137984 |
---|---|
author | Hou, Yafei Kohanbash, Gary Okada, Kaori Shrivastav, Shruti Smith-Cohn, Matthew Nicolaides, Theodore Mueller, Sabine Carcaboso, Angel Pollack, Ian Okada, Hideho |
author_facet | Hou, Yafei Kohanbash, Gary Okada, Kaori Shrivastav, Shruti Smith-Cohn, Matthew Nicolaides, Theodore Mueller, Sabine Carcaboso, Angel Pollack, Ian Okada, Hideho |
author_sort | Hou, Yafei |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4652531 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46525312015-11-25 Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation Hou, Yafei Kohanbash, Gary Okada, Kaori Shrivastav, Shruti Smith-Cohn, Matthew Nicolaides, Theodore Mueller, Sabine Carcaboso, Angel Pollack, Ian Okada, Hideho J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4652531/ http://dx.doi.org/10.1186/2051-1426-3-S2-P445 Text en Copyright © 2015 Hou et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Hou, Yafei Kohanbash, Gary Okada, Kaori Shrivastav, Shruti Smith-Cohn, Matthew Nicolaides, Theodore Mueller, Sabine Carcaboso, Angel Pollack, Ian Okada, Hideho Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation |
title | Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation |
title_full | Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation |
title_fullStr | Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation |
title_full_unstemmed | Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation |
title_short | Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation |
title_sort | novel and shared neoantigen for glioma t cell therapy derived from histone 3 variant h3.3 k27m mutation |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652531/ http://dx.doi.org/10.1186/2051-1426-3-S2-P445 |
work_keys_str_mv | AT houyafei novelandsharedneoantigenforgliomatcelltherapyderivedfromhistone3varianth33k27mmutation AT kohanbashgary novelandsharedneoantigenforgliomatcelltherapyderivedfromhistone3varianth33k27mmutation AT okadakaori novelandsharedneoantigenforgliomatcelltherapyderivedfromhistone3varianth33k27mmutation AT shrivastavshruti novelandsharedneoantigenforgliomatcelltherapyderivedfromhistone3varianth33k27mmutation AT smithcohnmatthew novelandsharedneoantigenforgliomatcelltherapyderivedfromhistone3varianth33k27mmutation AT nicolaidestheodore novelandsharedneoantigenforgliomatcelltherapyderivedfromhistone3varianth33k27mmutation AT muellersabine novelandsharedneoantigenforgliomatcelltherapyderivedfromhistone3varianth33k27mmutation AT carcabosoangel novelandsharedneoantigenforgliomatcelltherapyderivedfromhistone3varianth33k27mmutation AT pollackian novelandsharedneoantigenforgliomatcelltherapyderivedfromhistone3varianth33k27mmutation AT okadahideho novelandsharedneoantigenforgliomatcelltherapyderivedfromhistone3varianth33k27mmutation |